Ganoderma is a genus of fungi best known for one species in particular: Ganoderma lucidum, the mushroom called reishi in Japan and lingzhi in China. It’s a woody, kidney-shaped mushroom with a glossy reddish-brown surface that grows on decaying hardwood trees. Used in traditional East Asian medicine for over 2,000 years, it has become one of the most widely sold medicinal mushrooms worldwide, available as powders, capsules, teas, and tinctures. Its reputation far outpaces what clinical research has confirmed, but the mushroom does contain a genuinely interesting collection of bioactive compounds.
Key Compounds Inside the Mushroom
Ganoderma lucidum contains three major groups of active compounds: polysaccharides (complex sugars), triterpenes (bitter-tasting fat-soluble molecules), and peptidoglycans (protein-sugar complexes). Each group appears to do different things in the body, and researchers have cataloged well over 100 triterpenes in the mushroom alone, more than 50 of which are unique to this species. These triterpenes, collectively called ganoderic acids, are responsible for the mushroom’s distinctly bitter taste.
The polysaccharides, particularly a type called beta-glucans, are water-soluble and tend to be the dominant active ingredient when the mushroom is brewed as a traditional tea or decoction. The triterpenes, by contrast, dissolve better in alcohol-based extracts. This distinction matters when choosing a supplement, because the preparation method determines which compounds you actually get.
Two Species, One Name
The Chinese Pharmacopeia recognizes two species as official “lingzhi”: Ganoderma lucidum and Ganoderma sinense. G. lucidum is the red variety most people picture, while G. sinense is darker, sometimes nearly black. For years, researchers assumed the triterpenes (ganoderic acids) were the primary medicinal compounds, which posed a problem since G. sinense contains very few of them. A systematic comparison published in Scientific Reports found the answer: polysaccharides from both species share the same structural features, the same sugar linkage patterns, and similar tumor-suppressive and immune-stimulating activity in laboratory models. This helps explain why both species have been used interchangeably in traditional practice for centuries.
How It Affects the Immune System
The best-studied biological effect of Ganoderma is its interaction with immune cells. Its polysaccharides activate macrophages (cells that engulf pathogens), promote the proliferation of white blood cells, and stimulate the production of signaling molecules like interleukin-2 and interferon-gamma, both of which help coordinate the immune response. The triterpenes also enhance the killing ability of natural killer cells, a type of immune cell that targets virus-infected and abnormal cells.
These immune effects are well-documented in cell and animal studies. Whether they translate into meaningful clinical benefits for healthy people remains less clear. The immune-stimulating properties have drawn the most serious attention in cancer support research, where the mushroom has been studied as an add-on to conventional treatment rather than a standalone therapy.
What the Cancer Research Shows
A Cochrane review, the gold standard for evaluating medical evidence, identified five randomized trials involving 373 cancer patients who received Ganoderma or a placebo alongside their regular treatment. The findings were mixed but cautiously suggestive. In three studies covering 284 people, roughly 75 out of 100 patients taking Ganoderma reported better quality of life, compared to about 30 out of 100 in the control group. Four studies found modest increases of 2 to 4 percent in key immune cell counts (CD3, CD4, and CD8 T-cells). The effect on natural killer cell activity was inconsistent, with one study showing improvement and another showing the opposite.
The reviewers rated the overall evidence as low to very low quality. Side effects were minimal: across all five studies, only three people reported nausea or insomnia, and no liver abnormalities were found. The takeaway is not that Ganoderma treats cancer, but that it may offer some immune and quality-of-life support when used alongside conventional therapy. No major medical organization recommends it as a cancer treatment on its own.
Cardiovascular and Blood Sugar Claims
Despite frequent marketing claims about heart health, clinical trial data on cardiovascular outcomes is disappointing. A Cochrane-style review pooling results from controlled studies found no significant reduction in LDL cholesterol, blood pressure, triglycerides, fasting blood sugar, or hemoglobin A1c (a marker of long-term blood sugar control) at any time point measured, from 8 weeks out to 24 weeks. One measure of blood sugar after meals showed a slight benefit, but another measure at the same time point favored placebo. The results were too inconsistent and the studies too small to draw firm conclusions.
This doesn’t mean the mushroom has zero metabolic effects. Lab and animal studies consistently show antioxidant activity: the polysaccharides boost the body’s production of protective enzymes like superoxide dismutase and catalase, scavenge free radicals, and reduce markers of inflammation. Polysaccharides from the fruiting body specifically have been shown to lower lipid peroxidation (a type of cellular damage from oxidative stress) in animal tissues including liver, heart, and skeletal muscle. But these laboratory effects haven’t translated into measurable improvements in human clinical trials so far.
Fruiting Body vs. Mycelium
Ganoderma supplements are made from either the fruiting body (the visible mushroom cap) or the mycelium (the root-like network that grows through wood or grain). These are not nutritionally equivalent. Research comparing metabolite profiles across edible fungi found that fruiting bodies generally contain higher concentrations of antioxidant compounds like phenols and ergothioneine, while mycelium tends to accumulate more ergosterol (a precursor to vitamin D2) and certain cholesterol-lowering compounds. For Ganoderma specifically, the fruiting body is the traditional source and contains the full spectrum of triterpenes that give it its characteristic bitter flavor. Mycelium-based products, especially those grown on grain, often contain significant starch from the growing medium, which dilutes the concentration of active compounds.
Dosage and Forms
The standard dose of a basic Ganoderma extract (essentially dehydrated mushroom powder) ranges from about 1.4 to 5.2 grams per day. The most commonly studied dose is 5.2 grams, typically split into three servings of roughly 1,800 milligrams. Because drying concentrates the mushroom about tenfold, 5 grams of extract is roughly equivalent to 50 grams of fresh whole mushroom. Alcohol-based (ethanolic) extracts are far more concentrated and are dosed at around 6 milligrams per day, reflecting their higher triterpene content.
The form you choose should match what you’re looking for. Water extracts and teas emphasize polysaccharides. Alcohol extracts emphasize triterpenes. Dual-extraction products aim to capture both. Dried whole mushroom powder contains everything but at lower concentrations per gram.
Safety Concerns
Ganoderma is generally well tolerated in clinical trials, with most studies reporting few or no adverse events. However, there are documented cases of serious liver injury. One published case described fatal fulminant hepatitis in a patient who switched from traditionally boiled lingzhi tea to consuming the raw powder for one to two months. Another case involved acute hepatitis appearing just two days after someone took lingzhi powder while also drinking alcohol.
This alcohol interaction is particularly worth noting. Ganoderma has been shown to directly inhibit CYP2E1, a liver enzyme responsible for breaking down ethanol. Blocking this enzyme while drinking could cause alcohol and its toxic byproducts to accumulate. Current product labels typically do not warn about this interaction. If you drink regularly, this is something to take seriously. People with existing liver conditions, those taking medications processed by the liver, or anyone on blood thinners or immunosuppressant drugs should be cautious, as the mushroom’s bioactive compounds could interact with these medications in ways that haven’t been fully studied.